Home - Products - Others - Other Targets - 3β,15α-Dihydroxy-7,11,23-trioxolanost-8-en-26-oic acid

3β,15α-Dihydroxy-7,11,23-trioxolanost-8-en-26-oic acid

CAS No. ———

3β,15α-Dihydroxy-7,11,23-trioxolanost-8-en-26-oic acid( ——— )

Catalog No. M38487 CAS No. ———

3β,15α-Dihydroxy-7,11,23-trioxolanost-8-en-26-oic acid

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    3β,15α-Dihydroxy-7,11,23-trioxolanost-8-en-26-oic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    3β,15α-Dihydroxy-7,11,23-trioxolanost-8-en-26-oic acid
  • Description
    3β,15α-Dihydroxy-7,11,23-trioxolanost-8-en-26-oic acid
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    ———
  • Formula Weight
    ———
  • Molecular Formula
    ———
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Isogarcinol

    Isogarcinol (Cambogin) is a potent AChE and BChE inhibitor, with IC50 values of 1.13 and 8.30 μM, respectively. Isogarcinol also shows leishmanicidal activity, with an IC50 of 0.33 μM against L. donovani.

  • BV02

    BV02 is an inhibitor of 14-3-3 protein-protein interactions and can be used in studies about the treatment of chronic myeloid leukemia. BV02 disrupts hematopoietic cells expressing the IM-resistant T315I mutation and the IM-sensitive wild-type Bcr-Abl.

  • NE 10790

    NE 10790 is a phosphonocarboxylate analogue of the potent bisphosphonate risedronate and is a weak anti-resorptive agent.